Members of the Paediatric Neuroimaging Research Group at the University of Oxford (based at the Newborn Care Unit) decided to team up to support SSNAP (Support for Sick Newborns And their Parents). The team of four (Simon Marchant, Maz Aspbury, Luke Baxter and Marianne van der Vaart) signed up for the Oxford half marathon on 16th October 2022 to raise money for the charity through sponsorship. A couple of injuries meant that only two crossed the finish line, but they put in enough effort for the whole team!
Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK\u2019s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers. They have demonstrated the impact of the vaccine in generating herd protection, also called herd immunity, that protects all age groups.
IDRM hosted a full day of scientific talks and networking on the 4th of November at its Inaugural Symposium. The event was made possible by the generous donation of the J.W. Jenkinson Trust and the support from Nanostring, Sony, Integra, and Evox Therapeutics.
Health and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.
On Wednesday 21st September, the Department of Paediatrics invited friends, colleagues, and supporters of the department to celebrate its 50th Anniversary at the Mathematical Institute situated next to the Old Radcliffe Infirmary.
If you've ever wondered about the role of the muscle, come and meet us at IF Oxford - the Oxford science and ideas Festival on Saturday 8th & 15th October, when our researchers will be challenging members of the public to play our \"Muscle Switch\" game and exploring why strength differs between us.
Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. Eight of the 2021-22 awards, announced today, honour Oxford University researchers for their outstanding contributions to science and medicine.
Oxford University\u2019s Professor Teresa Lambe, the designer of the vaccine, fears Marburg disease is \u2018now being seen in places where it\u2019s never been seen before\u2019
When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.
A celebration for the opening of our Institute took place on Tuesday 12 July 2022 in the IMS-Tetsuya Nakamura Building, which was supported by a very generous donation from Dr Tetsuya Nakamura, Chief Director of Itabashi Medical System Group (IMS-Group), and substantial fund-raising from the British Heart Foundation (BHF).
Researchers from Oxford\u2019s Department of Paediatrics have discovered that infection can increase a baby\u2019s sensitivity to pain, which may last longer than the infection.
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
The James Spence Medal is the highest honour awarded by the RCPCH, and is awarded for outstanding contributions to the advancement of knowledge and understanding in paediatrics and child health.
On Wednesday 15th June, the Department of Paediatrics invited its members of staff and selected guests to join them at the Oxford University Museum of Natural History to embark on special evening of celebrations, commemoration, and entertainment.
It is a tragedy for a child to be diagnosed with a severe and disabling lifelong medical condition. But in addition to the child\u2019s difficulties and suffering and the emotional cost to their family, such maladies can also create a significant financial cost to both the family and to society; whether due to the cost of treatments, the expense of medical equipment and home adaptations, or indeed the loss of a family\u2019s productivity.
![\"\"](\"https://www.paediatrics.ox.ac.uk/news/paediatric-neurorunners-for-ssnap-take-on-oxford-half-marathon/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n